telmisartan has been researched along with Amyloid Angiopathy, Cerebral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang Li, J; Du, GT; Hong, H; Hu, M; Liu, GJ; Long, Y; Mei, ZL; Miao, MX; Wang, C | 1 |
1 other study(ies) available for telmisartan and Amyloid Angiopathy, Cerebral
| Article | Year |
|---|---|
Telmisartan treatment ameliorates memory deficits in streptozotocin-induced diabetic mice via attenuating cerebral amyloidosis.
Topics: Administration, Oral; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Angiotensin II Type 1 Receptor Blockers; Animals; Aspartic Acid Endopeptidases; Benzimidazoles; Benzoates; Cerebral Amyloid Angiopathy; Cerebral Cortex; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Hippocampus; Male; Memory Disorders; Mice; Mice, Inbred ICR; Peptide Fragments; Receptor for Advanced Glycation End Products; Streptozocin; Telmisartan; Transcription Factor RelA; Treatment Outcome | 2014 |